CORONA
NSECORONA Remedies Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,042.80
20.00 (0.99%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹12.49K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,336.6+52.8%
52W High₹2,100.7-2.8%
Current Price
₹2,042.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,634.24
Upper Circuit₹2,451.36
Reference Price
₹2,042.80
Investment Checklist
Bull Flag on 1D — target ₹2178.3
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
79%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1928.32
EMA50
1819.59
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹2100.70
Support (Below)
₹1949.40
₹1785.90
₹1724.00
₹1699.00
₹1660.52
Volume Analysis
TrendDECREASING
Change-67.80%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹2022.37
3% Risk₹1981.52
5% Risk₹1940.66
7% Risk (Custom)
₹1899.80Technical Levels
1x ATR (Volatility)₹1967.63
2x ATR (Swing)₹1892.46
3x ATR (Trend)₹1817.29
Immediate Support₹1949.40
Moving Averages
EMA 9 (Short-term)₹1992.29
EMA 20 (Medium-term)₹1928.32
EMA 50 (Trend)₹1819.59
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹297.7 Cr | ₹292.8 Cr | ₹346.3 Cr | ₹342.4 Cr |
| Net Profit | ₹45 Cr | ₹31.6 Cr | ₹46.2 Cr | ₹41.3 Cr |
| EPS | ₹7.35 | — | ₹7.55 | ₹6.75 |
| Operating Profit | ₹70.4 Cr | ₹53.3 Cr | ₹71 Cr | ₹66.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| CORONA Remedies Limited | ₹2,042.80 | +0.99% | — | ₹12.49K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Jun 2026 | Dividend - Rs 10 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CORONA
View All
positive
CNBC TV18 - Markets 8d ago
Corona Remedies CFO shares growth guidance
Ahmedabad-based pharmaceutical company Corona Remedies remains confident of delivering steady growth over the next few years, backed by its core brands, acquired portfolios and selective acquisitions.
CORONAHealthcare
positive
ET Markets - Stocks 23d ago
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
CORONAECAPINSUREESGFOCUSGICREGLOBALGODIGITGROWWCAPMGROWWMC150HDFCMID150HDFCNIF100HFCLICICIGIIFCILICNFNHGPLICNMID100LOWVOLLOWVOL1LOWVOLIETFMID150MID150BEESMID150CASEMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMIDSMALLMONIFTY100MOSERVICENETFNIF100BEESNIF100IETFNIFTY100EWNPBETSBINMID150SMALLCAPSML100CASETATATECHTMCVTMPVTNIDETFTOP100CASEAutomobile and Auto ComponentsCapital Goods
positive
Google News - India Markets 23d ago
Stocks to Watch Today: Rail Vikas Nigam, HFCL, Bosch Home Comfort, Lupin, Corona Remedies, Susan... - Moneycontrol.com
Stocks to Watch Today: Rail Vikas Nigam, HFCL, Bosch Home Comfort, Lupin, Corona Remedies, Susan...Moneycontrol.com
BOSCH-HCILBOSCHLTDCORONAHFCLLUPINRVNLAutomobile and Auto ComponentsConstruction